Surgery Partners, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Surgery Partners, Inc. reported a significant reduction in net loss and growth in revenue and Adjusted EBITDA for the fiscal year ended December 31, 2025, driven by same-facility performance and strategic acquisitions.
NASDAQ
Surgery Partners, Inc. reports a 13.5% increase in revenue and a 16.0% increase in Adjusted EBITDA for 2024, but also a net loss attributable to Surgery Partners, Inc. of $168.1 million.
NASDAQ
Surgery Partners, Inc. reports an 8% increase in revenue and a net loss of $11.9 million for the full year 2023, according to its 10-K filing.